SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Teles de Mendonca Ana Paula | President, Scent | 2026-08-17 | Open-market sell | 5718 | $476K |
| Birenkrant Marc | Controller & CAO | 2026-08-07 | Open-market sell | 1000 | $85K |
| DeVeau Michael | EVP, CFO | 2026-08-06 | Open-market sell | 8825 | $755K |
| FRIBOURG PAUL J | Director | 2026-06-01 | Open-market buy | 13500 | $1.0M |
| FRIBOURG PAUL J | Director | 2026-06-01 | Open-market buy | 260000 | $19.3M |
| Birenkrant Marc | Controller & CAO | 2026-05-04 | Option exercise | 389 | $0 |
| Birenkrant Marc | Controller & CAO | 2026-05-04 | Tax withholding | 141 | $10K |
| Borg Deborah | EVP, Chief Ppl&Culture Officer | 2026-05-04 | Option exercise | 1768 | $0 |
| Borg Deborah | EVP, Chief Ppl&Culture Officer | 2026-05-04 | Tax withholding | 713 | $50K |
| DeVeau Michael | EVP, CFO | 2026-05-04 | Option exercise | 884 | $0 |
| DeVeau Michael | EVP, CFO | 2026-05-04 | Tax withholding | 452 | $32K |
| Finzel Ralf | EVP, Global Operations Officer | 2026-05-04 | Option exercise | 1326 | $0 |
| Finzel Ralf | EVP, Global Operations Officer | 2026-05-04 | Tax withholding | 734 | $51K |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | Option exercise | 708 | $0 |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | Tax withholding | 362 | $25K |
| Arora Yuvraj | President, Taste & CCO | 2026-05-01 | Option exercise | 3572 | $0 |
| Arora Yuvraj | President, Taste & CCO | 2026-05-01 | Tax withholding | 1828 | $129K |
| Birenkrant Marc | Controller & CAO | 2026-05-01 | Option exercise | 397 | $0 |
| Birenkrant Marc | Controller & CAO | 2026-05-01 | Tax withholding | 144 | $10K |
| Borg Deborah | EVP, Chief Ppl&Culture Officer | 2026-05-01 | Option exercise | 2381 | $0 |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
A $1.153B impairment charge was realized and regulatory exposure broadened materially across three new fronts (TSCA/EPA, international trade law, and new tax legislation), while ongoing portfolio restructuring continues to generate stranded-cost and dis-synergy risk. These worsening factors are partially offset by a substantial 33% debt reduction and removal of covenant-relief language, signaling meaningfully improved balance-sheet flexibility. The net picture is mixed but tilts toward incremental stress, with regulatory and operational disruption risks now more prominent than a year ago.
4 company-specific · 3 eased/removed · 4 common-mode
Prior year disclosed anticipated $1.0–1.5B impairment charge. Current year confirms $1.153B impairment charge was recorded, plus warns future restructuring may trigger additional impairments. Material realized loss.
Any impairment of our tangible or intangible long-lived assets, including goodwill, may adversely impact our profitability. A significant portion of our assets consists of long-lived assets…
Revised language escalates strategic transformation risk, adds specific Food Ingredients divestiture consideration, emphasizes stranded costs, dis-synergies, and management distraction from ongoing portfolio optimization.
If we are unable to successfully execute our strategic transformation, or enter into or close collaborations, joint ventures, partnerships, acquisitions, or divestitures, it may have a material…
New disclosure of ongoing strategic transformation, segment reorganization, and cost reallocations actively impacting employee roles—escalates from generic talent risk to concrete operational disruption.
Our inability to recruit, retain or transition employees could adversely affect our ability to compete and achieve our strategic goals. Attracting, developing, and retaining talented employees…
New explicit disclosure of US TSCA regulatory challenges with major EPA delays and restrictive conditions, escalating compliance burden and cost risk.
Risks Related to Legal and Regulatory Considerations If we are unable to comply with regulatory requirements and industry standards, including those regarding product safety, quality, efficacy and…
Total debt decreased materially from $8.977B to $5.994B (33% reduction). Covenant relief period language removed, indicating improved financial position and reduced leverage constraints.
We have a substantial amount of indebtedness that could materially adversely affect, among other things, our financial condition, our ability to return capital to our shareholders, needed investments…
Removal of strategic transformation/portfolio optimization risk indicates successful completion of major divestitures and transactions, reducing execution risk.
If we are unable to successfully execute our strategic transformation, including our portfolio optimization, it may have a material adverse effect on our business, results of operations and financial…
Removal of detailed inflation and input-cost risk disclosure signals company views macro headwinds as materially eased or resolved, improving near-term outlook.
Inflationary trends and pricing uncertainty, including in the price of our input costs, such as raw materials, transportation and energy, could adversely affect our business and financial results in…
New explicit disclosure of pricing power risk: inability to pass cost increases to customers may reduce profits. Escalated emphasis on input cost inflation and competitive pricing pressure as material threats.
Trade wars, tariffs, sanctions, geopolitical developments, supply chain disruptions, environmental events, natural disasters, public health or human rights crises, and other events may adversely…
Debt risk factor expanded to explicitly address liquidity, flexibility, and cost of capital impacts from covenants—substantive escalation of financial risk disclosure.
ITEM 1A. RISK FACTORS. Risk Factor Summary The following summary highlights some of the principal risks that could adversely affect our business, financial condition or results of operations. This…
New explicit disclosure of international trade law compliance risks (duties, tariffs, anti-boycott, dumping) with potential fines and reputational harm. Materially expands regulatory exposure beyond FCPA/sanctions.
We could be adversely affected by violations, by us or our counterparties, of U.S. or foreign anti-bribery, international trade, anti-corruption, antitrust or competition laws and regulations…
New tax legislation (OBBBA 2025) disclosed; expanded discussion of tax uncertainty and cumulative effects on operating results and effective tax rate.
Changes in our tax rates, the adoption of new U.S. or international tax legislation, or changes in existing tax laws could expose us to additional tax liabilities that may affect our future results.…
IFF disclosed second quarter 2026 financial results via press release dated August 4, 2026, reporting consolidated sales of $1.95 billion, income before taxes of $64 million, and adjusted operating EBITDA of $408 million for Q2 2026 on a continuing operations basis, along with full-year 2026 guidance.
View raw filing on EDGAR →IFF entered into a definitive Purchase Agreement on May 29, 2026, to sell its Food Ingredients business to CVC Capital Partners for approximately $3.8 billion in net cash proceeds, with expected close by end of Q2 2027. The company characterizes this as a strategic shift with major effect on IFF's operations and results, with the business classified as discontinued operations.
View raw filing on EDGAR →IFF is furnishing recast unaudited financial information (Exhibit 99.1) to reflect the reclassification of its Food Ingredients and SCL disposal groups as discontinued operations. While the underlying transaction (sale of Food Ingredients to CVC Capital Partners, announced May 29, 2026, expected to close by end of Q2 2027) is a material M&A activity, this Item 7.01 disclosure centers on the financial restatement/recast of historical periods to show the impact of the separation. The filing explicitly states "This Form 8-K and the accompanying Exhibit 99.1 do not restate any previously filed financial statements" but furnishes recast information for investor understanding. This is a financial disclosure supporting a major divestiture rather than the divestiture announcement itself, making it a financial-domain event that does not fit the specific M&A category.
View raw filing on EDGAR →IFF entered into a $1 billion senior unsecured delayed draw term loan facility on June 23, 2026, to refinance €800 million of Senior Notes due September 25, 2026. This represents a material creation of a new direct financial obligation.
View raw filing on EDGAR →IFF entered into a definitive Transaction Agreement on May 28, 2026, to sell its Food Ingredients business to Foxtrot US Bidco, Inc. (a CVC Capital Partners affiliate) for approximately $4.3 billion in enterprise value, with IFF receiving ~$3.8 billion in net cash proceeds and retaining a ~9.9% minority equity stake in the divested business.
View raw filing on EDGAR →